Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (340K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (45)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Labourier, E.
Right arrow Articles by Tazi, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Labourier, E.
Right arrow Articles by Tazi, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, Vol 26, Issue 12 2955-2962, Copyright © 1998 by Oxford University Press


ARTICLES

Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2/ASF splicing factor

E Labourier, F Rossi, IE Gallouzi, E Allemand, G Divita and J Tazi
Institut de Genetique Moleculaire de Montpellier (IGM), UMR 5535 CNRS, Universite Montpellier II, CNRS - BP 5051, 1919, route de Mende, F34293 Montpellier Cedex 5, France.

Human DNA topoisomerase I, known for its DNA-relaxing activity, is possibly one of the kinases phosphorylating members of the SR protein family of splicing factors, in vivo. Little is known about the mechanism of action of this novel kinase. Using the prototypical SR protein SF2/ASF (SRp30a) as model substrate, we demonstrate that serine residues phosphorylated by topo I/kinase exclusively located within the most extended arginine-serine repeats of the SF2/ASF RS domain. Unlike other kinases such as cdc2 and SRPK1, which also phosphorylated serines at the RS domain, topo I/kinase required several SR dipeptide repeats. These repeats possibly contribute to a versatile structure in the RS domain thereby facilitating phosphorylation. Furthermore, far-western, fluorescence spectroscopy and kinase assays using the SF2/ASF mutants, demonstrated that kinase activity and binding were tightly coupled. Since the deletion of N-terminal 174 amino acids of Topo I destroys SF2/ASF binding and kinase activity but not ATP binding, we conclude that at least two distinct domains of Topo I are necessary for kinase activity: one in the C-terminal region contributing to the ATP binding site and the other one in the N-terminal region that allows binding of SF2/ASF.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Malanga, A. Czubaty, A. Girstun, K. Staron, and F. R. Althaus
Poly(ADP-ribose) Binds to the Splicing Factor ASF/SF2 and Regulates Its Phosphorylation by DNA Topoisomerase I
J. Biol. Chem., July 18, 2008; 283(29): 19991 - 19998.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
C. Haynes and L. M. Iakoucheva
Serine/arginine-rich splicing factors belong to a class of intrinsically disordered proteins
Nucleic Acids Res., January 10, 2006; 34(1): 305 - 312.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Soret, N. Bakkour, S. Maire, S. Durand, L. Zekri, M. Gabut, W. Fic, G. Divita, C. Rivalle, D. Dauzonne, et al.
Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors
PNAS, June 14, 2005; 102(24): 8764 - 8769.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Tazi, N. Bakkour, J. Soret, L. Zekri, B. Hazra, W. Laine, B. Baldeyrou, A. Lansiaux, and C. Bailly
Selective Inhibition of Topoisomerase I and Various Steps of Spliceosome Assembly by Diospyrin Derivatives
Mol. Pharmacol., April 1, 2005; 67(4): 1186 - 1194.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Yu, E. Khan, M. A. Khaleque, J. Lee, G. Laco, G. Kohlhagen, S. Kharbanda, Y.-C. Cheng, Y. Pommier, and A. Bharti
Phosphorylation of DNA Topoisomerase I by the c-Abl Tyrosine Kinase Confers Camptothecin Sensitivity
J. Biol. Chem., December 10, 2004; 279(50): 51851 - 51861.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Soret, M. Gabut, C. Dupon, G. Kohlhagen, J. Stevenin, Y. Pommier, and J. Tazi
Altered Serine/Arginine-Rich Protein Phosphorylation and Exonic Enhancer-Dependent Splicing in Mammalian Cells Lacking Topoisomerase I
Cancer Res., December 1, 2003; 63(23): 8203 - 8211.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Marchand, P. Pourquier, G. S. Laco, N. Jing, and Y. Pommier
Interaction of Human Nuclear Topoisomerase I with Guanosine Quartet-forming and Guanosine-rich Single-stranded DNA and RNA Oligonucleotides
J. Biol. Chem., March 8, 2002; 277(11): 8906 - 8911.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Pilch, E. Allemand, M. Facompre, C. Bailly, J.-F. Riou, J. Soret, and J. Tazi
Specific Inhibition of Serine- and Arginine-rich Splicing Factors Phosphorylation, Spliceosome Assembly, and Splicing by the Antitumor Drug NB-506
Cancer Res., September 1, 2001; 61(18): 6876 - 6884.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. Allemand, R. Gattoni, H.-M. Bourbon, J. Stevenin, J. F. Cáceres, J. Soret, and J. Tazi
Distinctive Features of Drosophila Alternative Splicing Factor RS Domain: Implication for Specific Phosphorylation, Shuttling, and Splicing Activation
Mol. Cell. Biol., February 15, 2001; 21(4): 1345 - 1359.
[Abstract] [Full Text]


Home page
J Exp BotHome page
A. Balestrazzi, A. Chini, G. Bernacchia, A. Bracci, G. Luccarini, R. Cella, and D. Carbonera
Carrot cells contain two top1 genes having the coding capacity for two distinct DNA topoisomerases I
J. Exp. Bot., December 1, 2000; 51(353): 1979 - 1990.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
L. Lacroix, H. Lienard, E. Labourier, M. Djavaheri-Mergny, J. Lacoste, H. Leffers, J. Tazi, C. Helene, and J.-L. Mergny
Identification of two human nuclear proteins that recognise the cytosine-rich strand of human telomeres in vitro
Nucleic Acids Res., April 1, 2000; 28(7): 1564 - 1575.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. G. Ahuja, C. A. Felix, and P. D. Aplan
The t(11;20)(p15;q11) Chromosomal Translocation Associated With Therapy-Related Myelodysplastic Syndrome Results in an NUP98-TOP1 Fusion
Blood, November 1, 1999; 94(9): 3258 - 3261.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
E. Labourier, H.-M. Bourbon, I.-e. Gallouzi, M. Fostier, E. Allemand, and J. Tazi
Antagonism between RSF1 and SR proteins for both splice-site recognition in vitro and Drosophila development
Genes & Dev., March 15, 1999; 13(6): 740 - 753.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
E. Labourier, J.-F. Riou, M. Prudhomme, C. Carrasco, C. Bailly, and J. Tazi
Poisoning of Topoisomerase I by an Antitumor Indolocarbazole Drug: Stabilization of Topoisomerase I-DNA Covalent Complexes and Specific Inhibition of the Protein Kinase Activity
Cancer Res., January 1, 1999; 59(1): 52 - 55.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
T. Misteli, J. F. Caceres, J. Q. Clement, A. R. Krainer, M. F. Wilkinson, and D. L. Spector
Serine Phosphorylation of SR Proteins Is Required for Their Recruitment to Sites of Transcription In Vivo
J. Cell Biol., October 19, 1998; 143(2): 297 - 307.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Lisby, J. R. Olesen, C. Skouboe, B. O. Krogh, T. Straub, F. Boege, S. Velmurugan, P. M. Martensen, A. H. Andersen, M. Jayaram, et al.
Residues within the N-terminal Domain of Human Topoisomerase I Play a Direct Role in Relaxation*
J. Biol. Chem., June 1, 2001; 276(23): 20220 - 20227.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.